Fri, September 6, 2024
Thu, September 5, 2024
Wed, September 4, 2024

Patrick Trucchio Reiterated (ARWR) at Strong Buy and Held Target at $60 on, Sep 5th, 2024


//stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-60-on-sep-5th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $60 on, Sep 5th, 2024.

Patrick has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 3 analyists that currently disagree with Patrick


  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Monday, August 12th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, July 17th, 2024
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024

Publication Contributing Sources